Consider that, between 1975 and 1999, only nine medicines of the 1393 that were developed targeted the most neglected diseases. (This figure rises to 16 if one considers tuberculosis and malaria.3) Of the remaining 1377 medicines developed, only two made the World Health Organization’s Model List of Essential Medicines. All 16 new medicines for neglected diseases did. In the ensuing five years, an additional 163 drugs were brought to market, of which four were for the treatment of malaria and one targeted a neglected disease—the drug miltefosine for treatment of leishmaniasis.Click here to read the entire article.
Thursday, August 02, 2007
"New Prescriptions for Neglected Diseases"
That's the title of a new article just published in Open Medicine. From the article: